Sinusoidal obstruction syndrome historical perspective
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome historical perspective |
|
FDA on Sinusoidal obstruction syndrome historical perspective |
|
CDC on Sinusoidal obstruction syndrome historical perspective |
|
Sinusoidal obstruction syndrome historical perspective in the news |
|
Blogs on Sinusoidal obstruction syndrome historical perspective |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Historical Perspective
- Endophlebitis in the terminal hepatic venule was first described by a pathologist from Prague in 1905.[1]
- In the 1960s, studies on effects of hepatic vasculature by ionizing radiations were reported. [2][3]
- The concept of sinusoidal obstruction syndrome induced by either chemical or radiation toxicity was well established by mid-1960s as a separate entity from Budd-Chiari syndrome.[4]
Template
- First Sentence:
- [Disease name] was first discovered by [scientist] in [year] during/following [event].
- OR
- [Disease name] was first described by [scientist] in [year].
- Examples:
- Example 1:Shigella was first discovered by Dr. Kiyoshi Shiga following a bacillary dysentery outbreak in Japan in 1896.
- Example 2: Melanoma was first described by Hippocrates in the 5th century BC.
- Additional Sentences:
- Additional Sentence 1: In [year], the first [event] occurred/was first reported following/during [event].
- Additional Sentence 2: In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
- Additional Sentence 3: There have been several outbreaks of [disease] which are summarized below.
- Additional Sentence 4: [Disease name] was first described in [year] by [scientist].
- Additional Sentence 5: [Risk factor or cause] was first discovered to be associated with [disease] in [year].
- Additional Sentence 6: In [year], [scientist] was the first to discover the association between [risk factor] and development of [disease].
- Additional Sentence 7: In [year], [gene] mutations were first identified in the pathogenesis of [disease].
- Examples:
- Example 1: In 1918, the first major human influenza pandemic occurred.
- Example 2: In 2003, human-to-human transmission of avian influenza was first reported during the influenza A H5N1 outbreaks in Southeast and Central Asia.
- Example 3: In 1978, the first cell-cytotoxicity assay was developed by Te-Wen Chang to diagnose C. difficile infection based on fecal toxins A and B.
- Example 4: There have been several outbreaks of avian influenza which are summarized below.
- Example 5: In 1956, Henry Lancaster, an Australian mathematician, was the first to discover the association between UV radiation exposure and development of melanoma.
- Example 6: In 2003, BRAF mutations were first identified in the pathogenesis of melanoma.
References
- ↑ Fan CQ, Crawford JM (2014). "Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)". J Clin Exp Hepatol. 4 (4): 332–46. doi:10.1016/j.jceh.2014.10.002. PMC 4298625. PMID 25755580.
- ↑ Dormoy A, Urlacher A, Tongio MM (1990). "A nucleotide substitution in a Bg1 II site is responsible for the RFLP discrimination between DPw4 and DPa". Tissue Antigens. 36 (3): 129–35. PMID 1980552.
- ↑ STIRLING GA, BRAS B, URQUHART AE (1962). "The early lesions in veno-occlusive disease of the liver". Arch. Dis. Child. 37: 535–8. PMC 2012933. PMID 13984193.
- ↑ GIBSON JB (1960). "Chiari's disease and the Budd-Chiari syndrome". J Pathol Bacteriol. 79: 381–401. PMID 13827970.